The phrase "a modifier and a" is correct and usable in written English.
It can be used when discussing grammatical elements, particularly in the context of sentence structure or parts of speech.
Example: "In the sentence, 'The quick brown fox jumps over the lazy dog,' 'quick' is a modifier and a descriptor of the noun 'fox.'"
Alternatives: "a qualifier and a" or "an adjective and a".
The findings at this conference acknowledged that being female may be a modifier and a possible increased risk for concussion (McCrory P, et. al. Br J Sports Med 2013).
The manual inspection of the word alignment variability showed that the most common differences are if a sequence of words is treated as a single name or if the words are split up in a modifier and a name.
The number of differences when a sequence of words is treated as a single name in one alignment and a modifier and a name in another alignment could maybe have been fewer with a slightly modified study.
An example of a single name could be 'Down's syndrome' and of a modifier and a name could be 'malignant neoplasm', but in the problematic cases the border between single names or modifiers and names were fuzzier than in these examples.
Accidentals have three defining attributes: a name, a modifier, and an alter.
Both as a modifier and as a noun, dumb-ass should be hyphenated as an aid to avert pronunciation of the silent b.
From these results, those corresponding to several reaction mechanisms involving both a suicide substrate and a modifier, and which can be regarded as particular cases of the general case analysed here, can be directly and easily derived.
The presence of PMSF (a serine modifier) and PAO (a cysteine modifier) led to the inactivation of the enzyme, which meant that serine and cysteine residues were essential for its catalytic function.
The signal transducer and activator of transcription 3 STAT3 were identified as a CF modifier and as a differentially regulated gene itself as well as PIAS4 (protein inhibitor of activated STAT).
Furthermore, physical activity has been shown to have a U-shaped association with LBP, and was therefore considered to be an effect modifier and not a confounder.
LSD1, an epigenetic modifier, and PELP1, an estrogen receptor co-activator, integrate estrogen receptor ERα and HER2 receptor tyrosine kinase signaling to promote aromatase expression and hormone resistance in a preclinical model of post-menopausal breast cancer.
